Poliovirus therapy shows potential as cancer vaccine in lab studies
Duke researchers in the US use the modified virus to spur natural immune attack against…
Browsing: Poliovirus therapy
Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival…